KDIGO 2024 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease

Zusammenfassung

VOLUME 105 | ISSUE 4S | APRIL 2024 www.kidney-international.org KDIGO 2024 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease SUPPLEMENT TO KDIGO 2024 CLINICAL PRACTICE GUIDELINE FOR THE EVALUATION AND MANAGEMENT OF CHRONIC KIDNEY DISEASE Kidney International(2024)105(Suppl 4S), S117–S314S117 KDIGO 2024 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease S118Tables,figures, and supplementary material S124KDIGO Execut

Kerninformationen

Albuminuria categories in chronic kidney disease (CKD) S169Table 4. Use of GFR and albuminuria S171Table 5. Risk factors for CKD S174Table 6. Guidance for selection of additional tests for evaluation of cause S178Table 7. Description of initial and supportive tests for evaluation of GFR S179Table 8....

Medications that should be considered for temporary discontinuation before elective surgeries and potential perioperative adverse events associated with their continued use S253Table 33. Potential risk factors for contrast-associated acute kidney injury S256Table 34. Benefits and consequences of ear...

Hazard ratios for adverse outcomes using the continuous model of estimated glomerularfiltration rate (eGFR), comparison of the shape of associations between creatinine-based eGFR (eGFRcr) and creatinine and cystatin C–based eGFR (eGFRcr-cys) in the population with cystatin C (eGFRcr-cys population) ...

Fragen zu diesem Thema?

ClariMed durchsucht alle Leitlinien mit KI und liefert quellenbasierte Antworten in Sekunden.

Jetzt auf ClariMed suchen